Juvenescence is a clinical-stage drug development company focused on extending healthy lifespan through innovative medicines that target the fundamental mechanisms of aging. Their approach emphasizes the prevention of age-related diseases rather than merely treating them, aiming to enhance both longevity and quality of life. The company is on track to advance multiple clinical medicines, with five therapies expected to enter Phase I or II trials by 2025. These therapies utilize various modalities, including small molecules, biologics, and cell therapies, to address core aging pathways and facilitate early disease intervention.

The company also leverages advanced technologies such as artificial intelligence and data science to enhance drug development processes. Their adaptive clinical trial designs incorporate patient stratification and real-time analysis, which aim to provide meaningful efficacy readouts. Additionally, Juvenescence collaborates with a range of portfolio companies that focus on diverse technologies, including regenerative medicine, nutritional supplements, and digital health platforms, all aimed at maximizing the impact on healthy lifespan extension. Through these innovative approaches, Juvenescence is committed to transforming the landscape of aging and longevity.

Ireland

Juvenescence is a life sciences company developing therapies to modify aging and increase healthy human lifespan. The Juvenescence team consists of highly experienced drug developers, entrepreneurs, marketers, and investors with a significant history of success in pharmaceutical drug development, synthetic biology, and tissue and cellular engineering.

Juvenescence has a broad pipeline in development and is driving innovation, with a focus on discovering and developing these therapies to modify the aging process, through prevention and by regenerating damage, to support healthy aging and increase health span. 

Cardiovascular Diseases

Digestive System Diseases

Musculoskeletal Diseases

Nervous System Diseases

Pathological Conditions

Urogenital Diseases

Juvenescence

Liver disease

LyGenesis

Biologics

Fibrosis

Heart failure

BYOMass

Kidney disease

Epilepsy

Selah

Rheumatoid arthritis

Napa

Europe - West

Artificial Intelligence

Digital Health/Medicine

Regenerative Medicine

Small Molecule Pharmaceuticals

Therapeutic

Juvenescence

Company Details